AndhraNews.net
Home » Features » Health » Skin cancer

Skin cancer


About Skin cancer

In May 09, Michael Jackson is seen walking out of a store with a bag that showed 'Skin Cancer' on it.

Skin cancer in News

MedX Health Corp. Announces Issuance of Shares and Share Option Grant
MISSISSAUGA, ON--(Marketwired - December 31, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that, effective December 23, 2015, it has issued 3,253,437 common shares in settlement of a total of $406,565 of debt

Melanoma Treatments Made Great Strides in 2015
WASHINGTON, DC--(Marketwired - December 23, 2015) - Never been has there been a more hopeful time for patients with melanoma, according to the Melanoma Research Alliance (MRA). While once almost always fatal for anyone with metastatic melanoma, recent advances in treatment, many of which came to market in 2015, have given hope of a longer life, says the MRA.

Novartis announces Phase III studies of Jakavi show disease improvement in patients with myelofibrosis and polycythemia vera
Novartis International AG /Novartis announces Phase III studies of Jakavi show disease improvement in patients with myelofibrosis and polycythemia vera . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

LI Breast Cancer Summit a Phenomenal Success
According to the American Cancer Society, in 2015 it is estimated that 231,840 new cases of invasive breast cancer will be diagnosed among women and men. Excluding skin cancer, breast cancer is the most frequently diagnosed cancer for women which means that 1 in 8 women will develop breast cancer during her lifetime

MedX Health Corp. Announces Its Third Quarter 2015 Financial Results and Approval of Share Issuances
MISSISSAUGA, ON--(Marketwired - November 27, 2015) - MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announced its results for the three and nine months ended September 30, 2015, which are also available on SEDAR (www.sedar.com).

Melanoma Research Alliance Applauds Latest Approved Combination Therapy
WASHINGTON, DC--(Marketwired - November 10, 2015) - The Melanoma Research Alliance (MRA) hails the approval of yet another treatment for melanoma by the U.S. Food & Drug Administration (FDA). The latest approved therapy is the combination of Roche's vemurafenib (Zelboraf®) and cobimetinib (Cotellic®) for the treatment of patients with advanced metastatic melanoma.

On a Budget? Dermatologists Share Tips to Save on Skin Care Costs
November is National Healthy Skin Month, and member dermatologists from the American Academy of Dermatology want to set one thing straight: you don't need expensive skin care products to have glowing, healthy skin. In fact, they say, wearing a broad-spectrum, water-resistant sunscreen with an SPF of 30 or higher before going outdoors is one of the most effective ways to maintain healthy skin.

Fox National Security Correspondent Jennifer Griffin to Keynote Annual Breast Cancer Summit
Jennifer Griffin, National Security Correspondent for Fox News Channel and breast cancer survivor, will serve as keynote speaker for the Fifth Annual Breast Cancer Summit on Fri., Nov. 13 at the Woodlands in Woodbury, NY. The annual event is hosted by Long Island Plastic Surgical Group, PC

MRA Hails FDA Approval of Expanded Treatment for Melanoma
WASHINGTON, DC--(Marketwired - October 29, 2015) - The Melanoma Research Alliance (MRA) welcomes news that the U.S. Food & Drug Administration (FDA) has expanded the approval of Bristol-Myers Squibb's (BMS) ipilimumab (Yervoy®) to include its use as adjuvant therapy for patients with Stage III melanoma at high risk of recurrence after surgery

MedX Health Corp. Announces Proposed Debt Settlements
MISSISSAUGA, ON--(Marketwired - October 28, 2015) - MedX Health Corp. (TSX VENTURE: MDX), announces that it has entered into agreements to settle a total of $406,564.96 of debt owed to certain trade creditors and insider creditors, subject to all relevant consents and approvals. Under the Debt Settlement Agreements, a total of $77,609

MRA Lauds FDA Approval of First Vaccine for Melanoma Treatment
WASHINGTON, DC--(Marketwired - October 28, 2015) - The Melanoma Research Alliance (MRA) welcomes another exciting new chapter in the treatment of melanoma with the news that the U.S

Avita Medical Highlights ReCell(R) Findings Published in Journal of Cranio-Maxillo-Facial Surgery
Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a medical device company specializing in the treatment of wounds and skin defects, today announced results from a series of cases using ReCell® showing clinically significant improvements in the aesthetic outcomes of repaired complex facial defects resulting from surgical removal of non-melanocytic skin cancers (NMSC)

A Subset of Patients With Metastatic Melanoma Achieves Clinical Benefit From Combination of Immunotherapy and Radiation Therapy
SAN ANTONIO, TX--(Marketwired - October 19, 2015) - Immunotherapy combined with palliative radiation therapy (RT) for a subset of patients with metastatic melanoma reduces the growth and spread of the cancer, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 57th Annual Meeting.

Hemp, Inc. Reports on Hemp Industry News
Hemp, Inc. (OTC PINK: HEMP) is pleased report that the Hemp Industry continues to garner media attention as Pennsylvania shows favorable interest in legalizing industrial hemp and North Carolina awaits the signature of approval from Governor Pat McCrory to legalize industrial hemp.

MedX Health Corp. Selected by BodyCheck NL to Supply Its SIAscopy(TM) Skin Assessment Technology to Be Integrated in BodyCheck(TM) Testing Kits Internationally
MISSISSAUGA, ON--(Marketwired - October 05, 2015) - MedX Health Corp

Blind Clinical Study of NuGene's Light and Bright Gel(TM) Shows 89% of Participants Experience a 50% or More Improvement in Their Hyperpigmentation Appearance
NuGene International, Inc. ("NuGene") (OTCQB: NUGN), a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media, was recently featured in a study and presentation by Dr. Dendy Engelman, a NuGene Advisory Board member and Director of Dermatological Surgery at New York Medical College

Patients with aggressive form of melanoma lived for more than two years on average when taking Novartis therapies Tafinlar® + Mekinist®
Novartis International AG /Patients with aggressive form of melanoma lived for more than two years on average when taking Novartis therapies Tafinlar® + Mekinist® . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Merck and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Business Wire IndiaMerck and Pfizer announced that the US Food and Drug Administration (FDA) has granted avelumab*, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough Therapy designation for the treatment of patients with metastatic Merkel cell carcinoma (MCC) who have progressed after at least one previous chemotherapy regimen

Merck and Pfizer Announce Investigational Immunotherapy Avelumab Receives FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma
Business Wire IndiaMerck and Pfizer today announced that the US Food and Drug Administration (FDA) has granted avelumab*, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Fast Track designation for the treatment of metastatic Merkel cell carcinoma (MCC), a rare and aggressive type of skin cancer

Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Business Wire IndiaMerck and Pfizer today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation for the investigational cancer immunotherapy avelumab* for the treatment of Merkel cell carcinoma (MCC), a rare and aggressive type of skin cancer

Skin by Design of Upper Yorkville Now Offers VISIA Complexion Analysis
Editors Note: There is a photo associated with this release.

Austin Dermatologists Detail Most Effective, Least Damaging Skin Cancer Treatment
According to the Skin Cancer Foundation, every year more than two million people are diagnosed with skin cancer. Dr. Adam J. Mamelak and Dr. Miriam L. Hanson of Sanova Dermatology in Austin, TX say they routinely treat patients with a wide variety of skin cancers, including the most common form, basal cell carcinoma (BCC)

Good Samaritan Hospital Names New Chief of Dermatology
Good Samaritan Hospital in West Palm Beach, Florida has named Dr. Supriya Tomar Chief of Dermatology.

Biofrontera launches new addition Belixos® Gel to its derma-cosmetic line
Biofrontera AG /Biofrontera launches new addition Belixos® Gel to its derma-cosmetic line . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Further progress in international approval processes of Biofrontera's Ameluz®
Biofrontera AG /Further progress in international approval processes of Biofrontera's Ameluz®. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Biofrontera publishes report on the third quarter of 2014
Biofrontera AG /Biofrontera publishes report on the third quarter of 2014. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Dermatologists Share Skin Care Tips for Your 40s and 50s
Studies have demonstrated that exposure to ultraviolet (UV) radiation from the sun and indoor tanning damages the DNA in our skin cells. This not only increases a person's risk for skin cancer, it can also lead to premature skin aging in the form of wrinkles and sun spots. November is National Healthy Skin Month -- the perfect time to learn how to maintain healthy skin care habits.

Biofrontera AG hosts conference call on 13 November 2014 to present results of the third quarter 2014
Biofrontera AG /Biofrontera AG hosts conference call on 13 November 2014 to present results of the third quarter 2014 . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Ad hoc: Biofrontera to take over the sales and marketing of Ameluz® in Spain from Allergan
Biofrontera AG /Keyword(s): Misc. matters /Ad hoc: Biofrontera to take over the sales and marketing of Ameluz® in Spain from Allergan . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Charleston Plastic Surgeon Customizes Rhinoplasty for Improved Function and Aesthetics
Commonly referred to as a "nose job," rhinoplasty surgery can be used to alter the nose to correct breathing impairments and improve airflow. Additionally, rhinoplasty can also be performed to address cosmetic concerns by reshaping the bridge, tip of the nose, or nostril size. Dr

Specialist in Tampa Utilizes Multiple Approaches for Treating Sun Damage
According to current estimates, Tampa, FL experiences over 244 days of sunshine every year. Dr. Jeffrey A. Hunt, a specialist and Medical Director of Vein & Cosmetic Center of Tampa Bay, notes that exposure to so much UV radiation can have a damaging effect on skin, potentially increasing the risk for skin cancer. To combat the adverse cosmetic and health effects of excess sun exposure, Dr

San Diego Dermatologist Recommends Laser Skin Resurfacing to Combat Sun Damage
Though San Diego's year-round sunny weather is enticing to many, the sun's UVA/UVB rays can contribute to an increased risk of skin cancer and the development of unwanted skin conditions such as age spots, fine lines, and wrinkles, explains San Diego cosmetic dermatologist Deborah H. Atkin, MD

Columbus Doctor Reveals Technological Advances in Regenerative Medicine
Dr. David Dean of the Ohio State University Department of Plastic Surgery has been researching regenerative medicine for nearly two decades. His research during this time has made significant contributions toward the development of medical 3D printing and bone tissue engineering. Dr

Ad hoc: US regulatory authority gives green light to proposed approach towards approval of Ameluz® and BF-RhodoLED® in the USA
Biofrontera AG /Keyword(s): Misc. matters /Ad hoc: US regulatory authority gives green light to proposed approach towards approval of Ameluz® and BF-RhodoLED® in the USA . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Medigene receives patent for TCR-modified T cell immunotherapy in Australia
Medigene AG /Medigene receives patent for TCR-modified T cell immunotherapy in Australia. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Ad hoc: Biofrontera AG: Clinical program for US approval of Ameluz® approaches completion: Studies confirm excellent efficacy and safety
Biofrontera AG /Keyword(s): Misc. matters /Ad hoc: Biofrontera AG: Clinical program for US approval of Ameluz® approaches completion: Studies confirm excellent efficacy and safety . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

Vela Diagnostics Launches First CE-IVD Next-Generation Sequencing Oncology Panel for Melanoma Testing on the Automated Sentosa(R) NGS Workflow
Vela Diagnostics announced today the CE-IVD launch of the Sentosa® SQ Melanoma Panel for Next-Generation Sequencing (NGS)-based gene sequence variant detection and identification.

Austin Dermatologist Launches Specialty Site Devoted to Mohs Skin Cancer Surgery
Seeking to provide a practical resource on skin cancer treatments, Dr. Adam Mamelak, a dermatologist in Austin, recently announced the launch of his specialty website for The Austin Mohs Surgery Center

Merck Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Merck (MRK GY) (FWB:MRK) announced today that it has entered into a global agreement with Pfizer Inc. (NYSE:PFE) to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.

Galderma Initiates U.S. Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgery
Galderma, a global healthcare company focused on dermatology, today announced that it has initiated a Phase II clinical trial of a novel muscle relaxant in the United States

Medical Cannabis Financial Group, Inc. Announces Merger Transaction With Refill Energy, Inc.
Refill Energy, Inc. (PINKSHEETS: REFG), a Nevada Corporation (the "Company") announces the merger between Refill Energy, Inc. and Medical Cannabis Financial Group. Refill Energy, Inc. completed a reorganization with Medical Cannabis Financial Group, Inc., which is a software solutions company focused on solutions for the Medical Marijuana industry

Genomind to Exhibit at the American Academy of Anti-Aging (A4M) Congress
CHALFONT, PA--(Marketwired - December 13, 2013) - Genomind, a personalized medicine company, is pleased to announce their participation at the American Academy of Anti-Aging (A4M) 21st Annual World Anti-Aging Congress, to be held December 12-15, 2013 in Las Vegas, Nevada at the Venetian Hotel.

Laser Therapy at Austin Dermatology Can Improve Spider Veins, Scarring, and Other Conditions
Vascular lesions, usually appearing as red or purple spots or bumps on the skin, are now being treated with an innovative new laser technology called the VBeam® Perfecta at Sanova Dermatology, an Austin dermatology practice. Dr. Adam Mamelak and Dr

Richmond Plastic Surgeon's Blog Reveals Key Breast Reduction Information
In a recent blog post titled "Breast Reduction Q&A with Dr. Zemmel," Richmond plastic surgeon Neil J. Zemmel, MD, FACS sheds light on breast reduction surgery by answering some general questions relating to the procedure, as well as the three techniques he offers at his practice:

World's First Needle-Free, Patient-Controlled Tissue Expansion Device for Women Undergoing Breast Reconstruction Following Mastectomy Approved in Australia
AirXpanders Inc., a company developing novel technology for women who require tissue expansion for breast reconstruction following a mastectomy, today announced that AeroForm®, the world's first and only needle-free, patient-controlled tissue expansion system has been approved in Australia

Skinvisible Adds Innovative Sunless Tanning Products Available for Exclusive Licensing
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) is pleased to announce that is has successfully developed new additions to its sunless tanning product line formulated with its patented Invisicare® polymer delivery technology. Skinvisible's sunless products address all of the issues which are common with sunless tanning products, specifically odor, streaking and the longevity of the tan

Dermatologist in Austin Recognized as a "Top Screener" for Skin Cancer Screenings
Aiming to increase early detection of skin cancer, dermatologist Dr. Adam Mamelak offers free skin cancer screenings at his Austin practice, Sanova Dermatology. These free screenings are part of the "Choose Skin Health" program, implemented by the American Society of Dermatological Surgery (ASDS) and Neutrogena®. Dr

Tips to Protect Your Skin This Winter
(Family Features) From non-friendly weather conditions to itch-inducing dyes found in everyday products, your skin can be exposed to a variety of unexpected irritants. But, protecting and maintaining healthy, comfortable skin can be easy with simple tips and products.

Biofrontera AG: Allergan launches Ameluz® in Spain
Biofrontera AG /Biofrontera AG: Allergan launches Ameluz® in Spain. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Biofrontera AG: Patient recruitment started in phase III study for field-therapy of actinic keratosis
Biofrontera AG /Biofrontera AG: Patient recruitment started in phase III study for field-therapy of actinic keratosis . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Minneapolis Plastic and Reconstructive Surgeon Works to Restore Normalcy to Patients' Lives
With procedures such as rhinoplasty, face lift surgery, and other treatments, Minneapolis facial plastic surgeon Jess Prischmann, MD is accustomed to the meticulous level of detail required when working with the sensitive and delicate areas of the face. This level of care and concern that Dr

Cooper Clinic Welcomes Drs. Flora Kim and Helen Kaporis to Dermatology Team
Cooper Clinic announces the addition of two new dermatology physicians to the preventive medicine staff. Dr. Flora Kim, MD, FAAD, and Dr. Helen Kaporis, DO, have joined Cooper Clinic, specializing in Preventive and Cosmetic Dermatology.

Biofrontera AG: Actinic keratosis, most efficiently treated by Ameluz®, recognized as occupational disease
Biofrontera AG /Biofrontera AG: Actinic keratosis, most efficiently treated by Ameluz®, recognized as occupational disease . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Austin Dermatologist Ranked #1 in His Field for Active Social Media Focus on Skin Cancer
Common Sense, a blog run by the independent strategic communications firm WCG, recently released an article on doctors who use social media to initiate online discussions about cancer. Dr. Adam J. Mamelak, an Austin dermatologist, was listed among the top doctors involved in these conversations

Autumn's Essential Ingredients for Radiant Skin and Hair -- Presented by Skincare-News.com
Summer is just about over, and the coolness of fall is in the air. What many people don't know is that this change in seasons means a necessary change in skincare habits. The products appropriate for summer heat should be replaced by formulas that contain nourishing ingredients to keep skin hydrated in the dry fall and winter months. The latest article by Skincare-News

Gold Coast Plastic Surgery Practice Expands With Addition of Skin Cancer Specialist
Skin cancer is a serious concern for Australians, due to constant exposure to high levels of ultraviolet radiation. To address this critical issue, The Layt Clinic, a plastic surgery practice on The Gold Coast, has had Dr. Dan Perera join their Skin Cancer and Laser Clinic in Southport

Gorgeous Skin in the 40s and 50s: Habits to Make or Break - Presented by Skincare-News.com
A major concern for many women -- and some men -- is aging gracefully. Although heredity is a main factor in determining how well people age, many habits -- such as changes in lifestyle -- can help those who aren't genetically blessed create a radiant complexion. The latest article by Skincare-News

Working Mom's Beauty Survival Kit -- Presented by Skincare-News.com
Beauty can often take a backseat when a baby is born. With a busy life on the go, when is there time for a working mom to look beautiful? Fortunately, there are many things that moms can easily pack in their purse or diaper bag to keep them looking great -- even after putting in a 9-5 workday. The latest article by Skincare-News

Latest News From American Academy of Dermatology Scientific Meeting
The American Academy of Dermatology (Academy) is holding the Summer Academy Meeting 2013, its annual summer scientific meeting in New York, July 31 - August 4, at the New York Hilton Midtown. World-renowned dermatologists will present information on the latest research in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail conditions.

First in Asia, Intra Operative 3D Radioguided Surgery System at HCG
HealthCare Global Enterprises Ltd, The Specialist in Cancer Care, today organized a press conference on treating cancer patients for the 1st time in Asia, with Intra Operative 3D Radioguided Surgery System (SurgicEye). Dr

Sensitive Skin & Active Lifestyle: How to Maintain a Healthy Skincare Routine for Sensitive Skin in Every Season -- Presented by Skincare-News.com
An active lifestyle requires special consideration when it comes to a health and beauty routine. For outdoorsy types -- especially those with sensitive skin -- it helps to have a season-by-season guide to help stave off common skin irritations and conditions. The latest article by Skincare-News

Petra Rietschel MD: Skin Cancer Project Banks on a Cure for Melanoma
The Herald Sun has reported the Melbourne Melanoma Project recently became one of the largest tissue banks in the world. It indicated 1,000 individuals have donated to date. The success the tissue bank has experienced collecting donations caught the attention of physician and medical researcher Petra Rietschel MD who works to help those diagnosed with skin cancer.

New York Dermatologist on Importance of Skin Cancer Foundation
Dr. Paul M. Friedman, a New York dermatologist, is experienced in the treatment and diagnosis of skin cancer. Operating out of the Dermatology & Laser Surgery Center, his practice is dedicated to providing early and accurate diagnoses of skin cancers and uses the most precise and advanced treatment techniques. As evidence of his commitment to this mission, Dr

Biofrontera's Ameluz® accepted by the Scottish Medicines Consortium for use within the National Health Service
Biofrontera AG /Biofrontera's Ameluz® accepted by the Scottish Medicines Consortium for use within the National Health Service . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Singapore Partners with UK in Conference to Advance Skin Research
More than 150 scientists from academia, industry and the clinical community in Singapore and the United Kingdom are gathering at Biopolis this week. They will meet to exchange ideas and discuss the latest cutting-edge skin research on wound healing, skin cancer and stem cell therapy for skin, at the Translational Skin Biology Symposium

Cold Weather Skincare Tips and Tricks for Busy Kids and Parents -- Presented by Skincare-News.com
Need pointers on keeping kids' sensitive skin protected during the harsh winter months? Whether little ones suffer from a severe skin condition or have mildly sensitive skin, the latest article by Skincare-News.com Attention, Parents: Skincare Tips for Kids' Cold Weather Skin Protection provides a handy guide for kids of all ages and skin types

Skinvisible Granted US Patent for Stabilizing Retinoids
Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) (OTCBB: SKVI) today announced that it has been granted US Patent Number 8,299,122 for combining retinoic acid with its patented polymer delivery system, Invisicare®

San Diego Plastic Surgeon Employs "Passion 4 Performance" Approach
Dr. Scott R. Miller, a board-certified San Diego plastic surgeon, operates his practice with a patient-focused philosophy. To emphasize this patient first prioritization, Dr. Miller has developed a 4-step methodology he terms the "Passion 4 Performance" (P4P) approach

Modernizing Medicine Reaches Over 650 Specialty-Specific Medical Practices and Captures Over 12% of the Dermatology Market in the United States With Its Electronic Medical Assistant(TM)
Modernizing Medicine, the creator of the Electronic Medical Assistant™ (EMA), a cloud-based specialty-specific EMR application, announced today that it is now integrated in more than 650 healthcare practices across the country, including more than 12% of all dermatology offices, proving it is a solid player in the EMR space.

Biofrontera AG: Expansion of the international marketing of Ameluz®
Biofrontera AG /Biofrontera AG: Expansion of the international marketing of Ameluz®. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

COMP Alumnus Leaves Lasting Legacy
College of Osteopathic Medicine of the Pacific alumnus Don Arlan Anderson, DO '87, touched the lives of countless patients. Following his unexpected death last year at the age of 53, he also left a lasting legacy at his alma mater, donating $4.2 million to Western University of Health Sciences.

Petra Rietschel, MD: Breast Cancer Treatment May Prove Beneficial in Melanoma Cases
Cancer treatments have evolved a great deal over the last few decades, and many of today's researchers are focusing on ways in which they can combine and cross-prescribe these drugs to effectively combat a variety of conditions

New Jersey Plastic Surgeon to Participate in Breast Cancer Walk
As National Breast Cancer Awareness Month approaches, New Jersey plastic surgeon Dr. Luis Zapiach and his staff have announced their participation in the Making Strides Against Breast Cancer walk being held in Ridgefield Park, NJ on October 21st, 2012

A*STAR Scientists Identify Mutation That Causes Skin Hyperproliferation
Scientists have identified a mutation in a gene that causes patches of very thick skin to appear on the palms and soles of affected people. This skin disorder is related, albeit in a much milder form, to that of the Indonesian 'Tree Man', Dede Koswara(1)

Biofrontera AG and Bipharma B.V.: Launch of Ameluz® in the Netherlands
Biofrontera AG /Biofrontera AG and Bipharma B.V.: Launch of Ameluz® in the Netherlands. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Newport Beach Dermatologist on Ideal Treatments for Fall
Dr. Nancy Lee Silverberg, a board-certified Newport Beach dermatologist, performs a wide variety of cosmetic dermatological procedures at Silverberg Surgical & Medical Group. Whether a patient is seeking photodynamic therapy, Fraxel® Laser treatment, or chemical peels, Dr

PropThink: Celgene Nearing 52-week High on Abraxane Data, Upcoming PDUFA
By Jake KingCelgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast cancer

Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Galderma Pharma S.A. (“Galderma”), a global specialty pharmaceutical company focused on dermatology and Spirig Pharma A.G. (“Spirig”), a leading company in the development, production, and marketing of dermatological products, has announced that they have entered into a definitive agreement under which Galderma will acquire Spirig.

ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that abstracts for the upcoming Society for Melanoma Research meeting have been published online in the organization’s official journal at http://onlinelibrary.wiley.com/doi/10.1111/pcmr.12023/abstract

ABRAXANE Meets Primary Endpoint of Progression-Free Survival in Phase III Chemotherapy-Naïve Metastatic Melanoma Study
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) has announced results of its phase III, randomized, international study (CA033) of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in chemotherapy-naïve patients with metastatic melanoma

Sunbed ban 'could prevent 1 in 4 cases of skin cancer in under-40s'
Banning sunbed use could prevent a quarter of cases of the most common form of skin cancer in the under-40s, a new research suggests.

Smoking strongly associated with non-melanoma skin cancer in women
Women who have non-melanoma skin cancers are more likely to have smoked cigarettes as compared to women without skin cancer, a new study has claimed.

Why men are at higher skin cancer risk than women
Lower levels of an important skin antioxidant may be the reason behind males being more vulnerable to skin cancer than women, a new study has suggested.

Verisante Starts FDA Approval Process and Provides Operational Update
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF)(PINKSHEETS: VRSEF)(FRANKFURT: V3T) (the "Company" or "Verisante"), a leader in skin cancer detection technology, has begun the process to obtain US Food and Drug Administration (FDA) approval for Verisante Aura

Skincare & Beauty Calendar: Skincare-News.com Presents a Twelve-Month Guide to Complete Skin Transformation
People can extend their New Year's beauty resolutions past the typical two weeks that it takes to forget about lofty goals. By adopting one simple change each month, within a year anyone can dramatically improve the health, appearance and future condition of his or her skin. Follow the yearlong plan in Skincare-News

MMRGlobal Files 8-K on Deal Memorandum
(December 20, 2011) - MMRGlobal, Inc. (OTCBB: MMRF), a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced it filed an 8-K with the U.S. Securities and Exchange Commission regarding the signing of a Deal Memorandum with JER, Inc

Verisante Obtains Australian Approval
Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF)(PINKSHEETS: VRSEF)(FRANKFURT: V3T) (the "Company" or "Verisante"), a leader in skin cancer detection technology, announced today that it has received regulatory approval to market and sell the Verisante Aura in Australia.

MELA Sciences Announces Additions to Board of Directors
MELA Sciences (NASDAQ: MELA) today announced the appointment of several new directors to serve on its Board -- Robert Coradini, Mark Fabiani, John Goddard, James Noble, and David Stone.

Jane Iredale Mineral Cosmetics: "Skincare-News.com" Presents Beauty Tips for a Natural Skincare Routine
For women who haven't tried mineral makeup yet, the Jane Iredale product line is a great place to find natural eye shadows, foundations, lip colors and more. And the purity of the ingredients might be surprising, even to those who use mineral makeup on a regular basis. Skincare-News

Simple lifestyle changes may prevent more than 40 pc cancer cases
A new study including an Indian-origin researcher has found that more than 40 percent of all types of cancer in the UK could be prevented by avoiding unhealthy lifestyles and environmental risks.

Comment on this story

Share